Get started
Author

Walter C. Darbonne

Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand
1994 · Frederic J. de Sauvage, Philip E. Hass, et al. · Nature · 1,268
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
2009 · Daniel D. Von Hoff, Patricia M. LoRusso, et al. · New England Journal of Medicine · 1,118
PDF
A Receptor for the Malarial Parasite Plasmodium vivax : the Erythrocyte Chemokine Receptor
1993 · Richard Horuk, Chetan E. Chitnis, et al. · Science · 578
Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy.
1995 · D Pennica, K L King, et al. · Proceedings of the National Academy of Sciences · 553
Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors
2011 · Patricia M. LoRusso, Charles M. Rudin, et al. · Clinical Cancer Research · 545
Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin.
1991 · W C Darbonne, G C Rice, et al. · Journal of Clinical Investigation · 455
PDF
Endothelial Interleukin-8: A Novel Inhibitor of Leukocyte-Endothelial Interactions
1989 · M. A. Gimbrone, M. S. Obin, et al. · Science · 448
Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis
2009 · Hua Tian, Christopher A. Callahan, et al. · Proceedings of the National Academy of Sciences · 416
Ischemic Stroke Injury Is Reduced in Mice Lacking a Functional NADPH Oxidase
1997 · Claire E. Walder, Simon P. Green, et al. · Stroke · 345
Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models
2016 · Elizabeth A. Punnoose, Joel D. Leverson, et al. · Molecular Cancer Therapeutics · 310
Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells
1993 · K. Neote, W. Darbonne, et al. · Journal of Biological Chemistry · 291
Potential Mechanisms for Thrombocytopenia Development with Trastuzumab Emtansine (T-DM1)
2014 · Hirdesh Uppal, Estelle Doudement, et al. · Clinical Cancer Research · 222
Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils.
1990 · C A Hébert, F W Luscinskas, et al. · The Journal of Immunology · 197
Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody–drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer
2016 · J.F. Liu, K.N. Moore, et al. · Annals of Oncology · 132
PDF
Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells
2011 · Weiwei Chen, Tracy Tang, et al. · Proceedings of the National Academy of Sciences · 122
The human erythrocyte inflammatory peptide (chemokine) receptor. Biochemical characterization, solubilization, and development of a binding assay for the soluble receptor
1993 · Richard Horuk, Timothy J. Colby, et al. · Biochemistry · 99
A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors
2014 · Amita Patnaik, Patricia M. LoRusso, et al. · Cancer Chemotherapy and Pharmacology · 90
Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma
2021 · Kanwal Raghav, Suyu Liu, et al. · Cancer Discovery · 78
PDF
Preclinical pharmacokinetics, pharmacodynamics, and activity of a humanized anti‐CD40 antibody (SGN‐40) in rodents and non‐human primates
2006 · Sean K Kelley, Thomas Gelzleichter, et al. · British Journal of Pharmacology · 59
PDF
Preclinical pharmacokinetics, pharmacodynamics and activity of a humanized anti‐CD40 antibody (SGN‐40) in rodents and non‐human primates
2007 · S K Kelley, T Gelzleichter, et al. · British Journal of Pharmacology · 57
PDF
Learning and Confirming with Preclinical Studies: Modeling and Simulation in the Discovery of GDC-0917, an Inhibitor of Apoptosis Proteins Antagonist
2013 · Harvey Wong, Stephen E. Gould, et al. · Drug Metabolism and Disposition · 55
Direct histological processing of EUS biopsies enables rapid molecular biomarker analysis for interventional pancreatic cancer trials
2012 · Rebecca J. Brais, Susan E. Davies, et al. · Pancreatology · 54
Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients
2017 · Marius Ilie, Edith Szafer-Glusman, et al. · Oncotarget · 52
PDF
A phase II trial of atezolizumab and bevacizumab in patients with advanced, progressive neuroendocrine tumors (NETs).
2020 · Daniel M. Halperin, Suyu Liu, et al. · Journal of Clinical Oncology · 42
Assessment of Clinical Response Following Atezolizumab and Bevacizumab Treatment in Patients With Neuroendocrine Tumors
2022 · Daniel M. Halperin, Suyu Liu, et al. · JAMA Oncology · 41
PDF
Works count: 109
Citation count: 8,035
H-index: 30
I10-index: 40
Year
Topic
Type